Enavate Sciences GP, LLC
Net seller this quarter
$345M
7
-$3.34M
100.0%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 SION | $109M | 31.56% | 5.49% | Not reported | Q1 2025 |
 ZBIO | $99.5M | 28.80% | 6.19% | Not reported | Q4 2024 |
 IMNM | $76.6M | 22.17% | 3.19% | Not reported | Q4 2024 |
 BBOT | $20M | 5.80% | 3.28% | Not reported | Q3 2025 |
 CMPX | $17.1M | 4.94% | 4.32% | Not reported | Q4 2024 |
 UPB | $17M | 4.93% | 4.49% | Not reported | Q4 2024 |
 CAMP | $6.23M | 1.80% | 2.75% | -34.9% | Q4 2024 |
| Q1 2026 | |||||
| SION | $99.3M | 28.26% | 5.50% | Not reported | Q1 2025 |
| IMNM | $79M | 22.48% | 3.19% | -24.2% | Q4 2024 |
| ZBIO | $76.6M | 21.80% | 6.28% | Not reported | Q4 2024 |
| CMPX | $41.2M | 11.72% | 4.32% | Not reported | Q4 2024 |
| BBOT | $23.5M | 6.69% | 3.28% | Not reported | Q3 2025 |
| UPB | $22.1M | 6.30% | 4.52% | Not reported | Q4 2024 |
| CAMP | $9.66M | 2.75% | 4.22% | -27.8% | Q4 2024 |
| Q4 2025 | |||||
| ZBIO | $142M | 28.08% | 7.19% | +4.2% | Q4 2024 |
| IMNM | $102M | 20.21% | 4.22% | Not reported | Q4 2024 |
| SION | $102M | 20.12% | 5.54% | Not reported | Q1 2025 |
| UPB | $66.8M | 13.18% | 4.54% | Not reported | Q4 2024 |
| CMPX | $41.8M | 8.25% | 4.37% | Not reported | Q4 2024 |
| BBOT | $32.9M | 6.49% | 3.28% | Not reported | Q3 2025 |
| CAMP | $18.6M | 3.67% | 5.85% | -19.8% | Q4 2024 |
| Q3 2025 | |||||
| ZBIO | $83.5M | 25.49% | 8.91% | Not reported | Q4 2024 |
| SION | $72.9M | 22.25% | 5.57% | Not reported | Q1 2025 |
| IMNM | $55.8M | 17.05% | 5.20% | Not reported | Q4 2024 |
| UPB | $46.3M | 14.13% | 4.56% | Not reported | Q4 2024 |
| BBOT | $30.4M | 9.29% | 3.32% | New | Q3 2025 |
| CMPX | $27.3M | 8.32% | 4.39% | Not reported | Q4 2024 |
| CAMP | $11.4M | 3.47% | 8.08% | Not reported | Q4 2024 |